FUJIFILM Corporation today announced that it has signed a joint research agreement with the National Cancer Center Japan, a Tokyo-based national institution recognized for its leadership in cancer ...
Discover key Q3 2025 earnings insights for Maravai LifeSciences. Learn about revenue trends, cost reductions, and growth outlook.
The enzyme RNA polymerase II transcribes genes into messenger RNA. This process is guided by modifications to the enzyme's ...
Inside every cell, a finely tuned metabolic network determines when to build, recycle, or stop producing essential molecules.
The Kanazawa team led by Katsuya Sakai, discovered that CHD1 uses a flexible region to form tiny liquid-like droplets, called condensates, that act as hubs for controlling the activity of crucial ...
A Northwestern team transformed a common chemotherapy drug into a powerful, targeted cancer therapy using spherical nucleic ...
Tribune Content Agency on MSN
Scientists use nanotechnology to turn chemotherapy drug into cancer super cure
Scientists at Northwestern University in Evanston, Illinois, have used nanotechnology to re-engineer the molecular structure ...
An update from Veritas In Silico Inc. ( ($JP:130A) ) is now available. Veritas In Silico Inc. and Dexerials Corporation have announced a joint ...
By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward for cancer therapy, researchers at Northwestern University have redesigned ...
An artificial intelligence model predicts how brain immune cells react to RNA and DNA nanoparticles, helping scientists design safer and more effective nucleic acid therapies faster.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results